Potential Single Nucleotide Polymorphisms markers for radiation dermatitis in head and neck cancer patients: ameta-analysis.

Abstract

To identify potential Single Nucleotide Polymorphisms (SNPs) of susceptibility for the development of acute radiation dermatitis in head and neck cancer patients, and also to verify the association between SNPs and the severity of RD. This systematic review was reported according to the PRISMA guideline. The proportion meta-analysis was performed to identify the prevalence of genetic markers by geographical region and radiation dermatitis severity. The meta-analysis was performed to verify the association between genetic markers and RD severity. The certainty of the evidence was assessed by GRADE. Thirteen studies were included. The most prevalent SNPs were XRCC3 (rs861639) (36%), TGFβ1 (rs1800469) (35%), and RAD51 (rs1801321) (34%). There are prevalence studies in Europe and Asia, with asimilar prevalence for all SNPs (29-40%). The prevalence was higher in patients who developed radiation dermatitis ≤2 for any subtype of genes (75-76%). No SNP showed astatistically significant association with very low certainty of evidence. The most prevalent SNPs may be predictors of acute RD. The analysis of SNP before starting radiation therapy may be apromising method to predict the risk of developing radiation dermatitis and allow radiosensitive patients to have acustomized treatment. This current review provides new research directions.